The Division of Hematology/Oncology at Indiana University is a part of the Indiana University Health Melvin and Bren Simon Cancer Center, a National Cancer Institute (NCI)-designated Cancer Center since 1999, and the only center with such distinction in Indiana that provides patient care. The Division of Hematology Oncology is comprised of a diverse faculty with expertise in every major hematologic and oncology disease.
Learn about the program with this video
The faculty has played a major role in establishing the standards for care in various malignancies including germ cell tumors, breast cancer, thymoma and lung cancer. The Division has a multi-disciplinary clinic in prostate cancer, lung cancer, breast cancer, gastro-intestinal tumors, head and neck cancer, melanoma, testicular, bone marrow transplant, and precision genomics, among others.
In addition to their clinical expertise, IU faculty have been a part of serving as National and International leaders, including prior presidents of the American Society of Clinical Oncology (ASCO) [Dr. Lawrence Einhorn in 2000-2001 and Dr. George Sledge in 2010-2011] and the American Society of Hematology (ASH) [Dr. Hal Broxmeyer in 2010). Several faculty and former fellows serve in leadership capacities, including the Board of Directors for ASCO, members of the Oncology Drug Advisory Committee (ODAC) to the FDA, and Editors of major oncology journals including the Journal of Clinical Oncology (JCO). Excellent mentoring opportunities over the years have assisted many IU Hematology/Oncology Fellowship graduates in becoming National and International leaders in their respective fields.
First Row (Bottom Left to Right): Neda Hashemi Chief Fellow, Maitri Kalra, Anthony Betbadal, Marwan Mounayar, Srivanti Rangaraju, Olumide Gbolahan
Second Row (Top Left to Right): Nabin Khanal, Andrew O’Brien, Adam Miller, Alvaro Menendez, Mustafa Hyder, Vaibhav Agrawal, Shahid Ahmed
Our program is customizable to meet the career goals of our fellows. We devote a major teaching effort to maximize the likelihood that our trainees will have all requisite skills to compete successfully for research funding in academia and to be optimally prepared for careers in academic medicine as teacher- investigators, while at the same time preparing for a successful career in general hematology/oncology in a private practice setting. The program provides outstanding clinical training, excellent mentoring, and the ability to adapt the training experience to meet individual professional goals, within a nuturing and collegial atmosphere.
The Division of Hematology/Oncology at Indiana University offers a combined three year program. Fellows are offered the opportunity to be eligible for board certification in both disciplines of Hematology and Medical Oncology. Fellows also have the option of pursuing a two year program in one of the two sub-specialties. The number of fellows in our combined program is variable, based upon individual research interests of senior fellows. In general, 15 fellowship positions are available. Our Program has received the highest level of accreditation by the ACGME with a maximum cycle length of 5 years. During the period from 2013 to 2015, 100% of our fellows who were eligible for and elected to take ABIM certifying exams in Hematology and Medical Oncology received passing scores.
|Michael J. Robertson, MD
Professor of Medicine
Director, Lymphoma Program
Phone: (317) 948-6942
Fax: (317) 948-9302
|Naveen Manchanda, MD
Associate Professor of
Key Clinical Educator
Phone: (317) 948-7576
535 Barnhill Drive, RT 473
Indianapolis, IN 46202
Phone: (317) 948-6942
Fax: (317) 948-9302
Academic Opportunity | [Top]
Within the program, each fellow is expected to engage in a mentored research project during their fellowship. Unique opportunities exist for fellow research, including the Komen Tissue Bank, Brown Center for Immunology, Walther Cancer Institute, Regenstreif Institute, BIG 10 Research Consortium, and the Hoosier Cancer Research Network, which is a community based oncology group that provides excellent opportunity for fellow led clinical trial design. Support is available for additional training in Masters of Public Health, Masters of Clinical Research, and Clinical Pharmacology.
A list of the current hematology/oncology fellows at Indiana University and their research interests can be found here.
Nabil Adra, PGY6
Dr. Adra has a dedicated research focus in GU oncology and has presented his research at national meetings, including podium presentations at the ASCO annual conference. He says, " Fellowship at IU has provided exceptional clinical training with world experts in every discipline while offering solid education, mentorship, and infrastructure helping me launch my career in academic genitourinary oncology."
Jill Kremer, PGY6
Dr. Kremer is IU's first developmental therapeutics fellow, working with a special focus on phase 1 and drug development with IU Lilly. She says of the program, "It's like academics on steroids!"
Clinical Training | [Top]
Each fellow will have a continuity-of-care clinic throughout their 3 year fellowship, where the fellow is autonomous to care for a cohort of patients under the direction of committed faculty. This includes a hematology or oncology clinic at the VA Medical Center or Eskenazi Health. In addition, each fellow will have rotating 3-month sub-specialty clinics throughout their 3 years. Fellows also have the unique opportunity to rotate at Indiana Hemophilia and Thrombosis center, focusing on benign hematologic conditions. While on the in-patient or consult services at IU, Eskenazi, or the VA, the fellow plays a prominent role as the junior attending, supervised by a faculty member.
Our former fellows have spread scross the country at academic institutions and throughout the community to practice their skills.
Teaching and Mentorship | [Top]
Formal conferences are considered to be a central part of the fellow’s education. These include weekly subspecialty multi-disciplinary conferences, educational lecture series, academic half-days, grand rounds, and monthly journal club. Mentorship is provided by both individualized faculty and a formal mentoring committee.
- Weekly Case Conference and Lecture Series
- Weekly Lymphoma/Leukemia Fellows conference
- Weekly Cancer Center Grand Rounds
- Monthly Oncology Journal Club
- Monthly Academic “Half-Day,” a unique learning experience with a Meet the Professor component
- Monthly Chief Rounds
- Annual ASCO Review Course
- Landmark Trials Series and Board Review Materials
- Immersion week for first year fellows, providing protected time to focus on learning core principles of hematology/oncology and concentrated orientation experience
- Research Foundation Workshop, designed to educate fellows on the basic skills of protocol and grant writing. Fellows are encouraged to apply for funding via this educational series.
The Circle City | [Top]
Our training program is in the heart of downtown Indianapolis. The fellows enjoy spending time together outside of work exploring Indianapolis, including Mass Ave
, Broad Ripple
and the Canal
. More about Indianapolis can be found here